TNFRSF17 and autoimmune disease: Because the expression of BCMA is not restricted to B cells, it is important to consider the release of sBCMA by cellular sources such as pDCs in response to TLR stimulation in blocking therapies targeting the BAFF-APRIL system in autoimmune diseases such as SLE40.